TEBXELI Trademark
Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for TEBXELI with the United States Patent and Trademark Office. The USPTO has given the TEBXELI trademark a serial number of 98438630. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by GLAXO GROUP LIMITED. The TEBXELI trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
General Information
| Serial Number | 98438630 |
| Word Mark | TEBXELI |
| Filing Date | Thursday, March 7, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 19, 2024 |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 7, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | GLAXO GROUP LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
| Party Name | GLAXO GROUP LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Thursday, March 7, 2024 | NEW APPLICATION ENTERED |
| Thursday, March 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
| Thursday, September 19, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, September 19, 2024 | SUSPENSION LETTER WRITTEN |
| Thursday, September 19, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, October 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 10, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, October 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
